it is possible to treat breast cancer without surgery.
Click on the button to see a video that describes a typical treatment.
BackgroundIn Sweden about 10000 women are diagnosed with breast cancer every year. Comprehensive research has shown that there are two main types of breast cancer: low-risk tumours, which develop very slowly and high-risk tumours, which may rapidly develop into aggressive cancers with the ability to spread cancer cells to other organs.
Low-risk tumours account for more half of all breast cancers and mostly affect older women. Research shows unequivocally that early diagnosis and treatment of low-risk cancer results in over 95% ten-year survival. Most of these patients are currently exposed to overtreatment, which is stressful for patients and costly at the same time.
Together with the Karolinska Institutet, prof. Gert Auer demonstrated that low-risk breast cancer is genomically relatively stable, while the high-risk breast cancer type is genomicallly highly unstable. In cooperation with Danderyd hospital and S:t Göran hospital professor Hans Wiksell has developed and clinically tested a new method, which allows for gentle treatment of the non-aggressive still locally growing breast cancer.
How is it done?The TriMed® treatment begins with local anaesthesia, after which a thin treatment electrode is precision placed with help of mechanical micro pulses and ultrasound guidance. The electrode is equipped with anti-seeding device preventing dissemination of living cancer cells with help of short heat pulses. During the treatment phase the tumour is heated with preferential radiofrequency ablation technic to 70° C under accurate control.
Future proceduresToday NeoScience work together with researchers from the Karolinska Institutet to further develop the method and design equipment for launch to market. The aim of current cancer therapy is to offer each cancer patient an individual and effective treatment. This requires accurate clinical, high-resolution imaging and ultra-sensitive biomarker based diagnostics. Our results to date show that approximately 50% of all women with early detection of genomic stable breast cancer can be treated on an individual basis.
Treatment today1. Image analysis
2. Tissue sampling
3. Pathological examination
4. Surgical removal of the breast tumour
5. Time of hospital stay
7. After-care, chemotherapy, radiotherapy
Treatment with TriMed®1. Image analysis
2. Fine-needle-aspiration cytology and DNA-analysis
3. Local heat treatment
4. The patient is cured and can leave the hospital after one hour